More countries are drawing up plans to tackle antimicrobial resistance (AMR), but major gaps in testing and treatment mean billions of people continue to be at risk, according to new data released by the World Health Organization (WHO) on Monday.
When medicines lose their power against drug-resistant microbes, common infections become harder to treat, and routine procedures such as surgery, childbirth and cancer care become riskier.
In 2023, around one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotics.
The findings, released ahead of World AMR Awareness Week , show that 173 countries report having developed plans to address AMR - more than double the 79 that did so in 2017.
However, only 22 per cent of countries report having both the necessary funding and full implementation of their national action plans, leaving major gaps from preventing infections to diagnosing and treating patients.
"National plans are essential for protecting the medicines that protect us, and the fact that most countries now have plans in place is great news," said WHO Director-General Tedros Adhanom Ghebreyesus .
"But an unfulfilled plan helps no one."
Diagnosis falls short
Testing remains inadequate in most countries. Only 36 per cent report having a national reference laboratory equipped to test the selected bacteria and fungi - far short of the global target of 80 per cent of countries having comprehensive bacterial and fungal resistance testing capacity by 2030.
Without adequate testing, patients are more likely to be prescribed antibiotics that are ineffective or unnecessary, and resistant infections and outbreaks may go undetected.
The gaps extend to treatment guidelines and surveillance. Only 63 per cent of countries report having guidelines on the appropriate use of antimicrobials, and just over half report having systems to monitor national antibiotic use and track levels of AMR.
'Prevent AMR now'
The data come from the latest Tracking Antimicrobial Resistance Country Self-assessment Survey (TrACSS), completed by 183 countries this year.
World AMR Awareness Week runs from 18 to 24 November under the theme One Health, one action: Prevent AMR now.
"Every infection prevented means fewer antimicrobials are needed, and testing ensures that patients receive the right treatment only when necessary," said Tedros, urging all countries to invest in infection prevention, surveillance, equitable access to essential antimicrobials and quality diagnostics.